Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Safety of nab-paclitaxel plus sunitinib: analysis of three cases.

Dudek AZ, Nguyen S.

Anticancer Res. 2008 Sep-Oct;28(5B):3099-105.

2.

nab-paclitaxel for the management of patients with advanced non-small-cell lung cancer.

Hirsh V.

Expert Rev Anticancer Ther. 2014 Feb;14(2):129-41. doi: 10.1586/14737140.2014.881719. Review.

PMID:
24467217
3.

Albumin-Bound Paclitaxel: A Review in Non-Small Cell Lung Cancer.

Blair HA, Deeks ED.

Drugs. 2015 Nov;75(17):2017-24. doi: 10.1007/s40265-015-0484-9. Review.

PMID:
26541764
4.

The current status and evolving role of sunitinib in non-small cell lung cancer.

Socinski MA.

J Thorac Oncol. 2008 Jun;3(6 Suppl 2):S119-23. doi: 10.1097/JTO.0b013e318174e9be. Review.

5.

Taxol (paclitaxel) in the treatment of lung cancer: the Eastern Cooperative Oncology Group experience.

Johnson DH, Chang AY, Ettinger DS.

Ann Oncol. 1994;5 Suppl 6:S45-50. Review.

PMID:
7865434
6.

Phase II study of carboplatin-paclitaxel combination chemotherapy in elderly patients with advanced non-small cell lung cancer.

Okamoto I, Moriyama E, Fujii S, Kishi H, Nomura M, Goto E, Kiyofuji C, Imamura F, Mori T, Matsumoto M.

Jpn J Clin Oncol. 2005 Apr;35(4):188-94. Review.

PMID:
15845567

Supplemental Content

Support Center